LEN
50
2
UNH
42
4
TSN
40
2
GILD
42
-3
CMA
50
10
ACN
42
2
ES
34
-2
RHI
40
2
HBAN
48
4
GOOGL
70
-2
DO
47
-2
DLTR
51
3
CMS
61
-3
ADI
59
2
EXR
53
2
HSY
50
2
R
63
2
UNP
55
6
LEG
22
6
KEY
50
7
LEN
50
2
UNH
42
4
TSN
40
2
GILD
42
-3
CMA
50
10
ACN
42
2
ES
34
-2
RHI
40
2
HBAN
48
4
GOOGL
70
-2
DO
47
-2
DLTR
51
3
CMS
61
-3
ADI
59
2
EXR
53
2
HSY
50
2
R
63
2
UNP
55
6
LEG
22
6
KEY
50
7
Financhill
Back

Central Garden & Pet Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
50

CENT
Central Garden & Pet

Last Price:
38.54
Seasonality Move:
1.29%
Buy
51

ALNY
Alnylam Pharmaceuticals

Last Price:
242.97
Seasonality Move:
20.36%
Sell
50
Central Garden & Pet (CENT) is a Sell

Is Central Garden & Pet a Buy, Sell or Hold?

  • The current Central Garden & Pet [CENT] share price is $38.50. The Score for CENT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • CENT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $243.08. The Score for ALNY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CENT Stock Price Chart

What is Central Garden & Pet's stock price today?

  • The Central Garden & Pet share price today is $38.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CENT is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $243.08
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.

CENT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.33 Sell
Relative Strength Index (14 RSI): 36.41 Sell
Chaikin Money Flow: 247704 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.4 - 43.48) Sell
Bollinger Bands (100): (39.69 - 44.27) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 22.91 Buy
Relative Strength Index (14 RSI): 86.77 Buy
Chaikin Money Flow: -1210062 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (135.8 - 205.74) Buy
Bollinger Bands (100): (136.44 - 176.64) Buy

CENT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.57 Sell
20-day SMA: 39.98 Sell
50-day SMA: 42.12 Sell
200-day SMA: 39.19 Sell
8-day EMA: 38.64 Sell
20-day EMA: 39.91 Sell
50-day EMA: 41.23 Sell
200-day EMA: 39.43 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 209.44 Buy
20-day SMA: 176.25 Buy
50-day SMA: 159.62 Buy
200-day SMA: 165.96 Buy
8-day EMA: 218.01 Buy
20-day EMA: 188.75 Buy
50-day EMA: 168.9 Buy
200-day EMA: 168.09 Buy

Central Garden & Pet Earnings Growth & CENT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.19 per share, an increase next quarter of $1.39 per share, a decrease this year of $0.29 per share, and an increase next year of $0.21 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.46 per share, and an increase next year of $1.83 per share.

Central Garden & Pet Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):